Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising.
Ontology highlight
ABSTRACT: The repair of DNA double-strand breaks (DSBs) is a critical cellular mechanism that exists to ensure genomic stability. DNA DSBs are the most deleterious type of insult to a cell's genetic material and can lead to genomic instability, apoptosis, or senescence. Incorrectly repaired DNA DSBs have the potential to produce chromosomal translocations and genomic instability, potentially leading to cancer. The prevalence of DNA DSBs in cancer due to unregulated growth and errors in repair opens up a potential therapeutic window in the treatment of cancers. The cellular response to DNA DSBs is comprised of two pathways to ensure DNA breaks are repaired: homologous recombination and non-homologous end joining. Identifying chemotherapeutic compounds targeting proteins involved in these DNA repair p
SUBMITTER: Jekimovs C
PROVIDER: S-EPMC4001069 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA